This work underscores the advancements in Surface-enhanced Raman scattering (SERS) technology, particularly in biomedicine. Known for its high sensitivity and resolution, SERS is a powerful tool for detecting low-concentration analytes. The study focuses on SERS-based nanosensors applied to imaging, biochemical monitoring, diagnostics, and therapy. By combining Raman spectroscopy with SERS, the research achieves precise HER2 quantification in breast cancer cells at the single-cell level, offering insights into cancer heterogeneity and supporting personalized treatments. Additionally, SERS is used to monitor Galunisertib delivery within living colorectal cancer cells, using diatomite-based nanovectors with gold nanoparticles and a pH-sensitive gelatin coating. This setup allows for controlled drug release in response to the tumor microenvironment, with real-time, label-free quantification of Galunisertib at very low concentrations. These findings highlight the potential of SERS to improve the precision and effectiveness of drug delivery and cancer treatment strategies.
|